Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-000657
Filing Date
2025-03-26
Accepted
2025-03-25 20:28:20
Documents
103
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3382982
2 ex21-1.htm EX-21.1 4186
3 ex31-1.htm EX-31.1 11246
4 ex31-2.htm EX-31.2 11417
5 ex32-1.htm EX-32.1 4589
6 ex32-2.htm EX-32.2 4706
7 form10-k_001.jpg GRAPHIC 10558
8 form10-k_002.jpg GRAPHIC 107926
9 form10-k_003.jpg GRAPHIC 80884
10 form10-k_004.jpg GRAPHIC 61101
11 form10-k_005.jpg GRAPHIC 77600
  Complete submission text file 0001641172-25-000657.txt   14162088

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE scnx-20241231.xsd EX-101.SCH 87227
13 XBRL CALCULATION FILE scnx-20241231_cal.xml EX-101.CAL 118089
14 XBRL DEFINITION FILE scnx-20241231_def.xml EX-101.DEF 418796
15 XBRL LABEL FILE scnx-20241231_lab.xml EX-101.LAB 750121
16 XBRL PRESENTATION FILE scnx-20241231_pre.xml EX-101.PRE 587779
105 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 2046998
Mailing Address 2420 BRUNELLO TRACE LUTZ FL 33558
Business Address 2420 BRUNELLO TRACE LUTZ FL 33558 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39199 | Film No.: 25769792
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)